medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2020, Number 4

<< Back Next >>

Acta Med 2020; 18 (4)

Binging eating disorder associated with depression and anxiety in patients with diabetes type 2

Ramos SDFI

Language: Spanish
References: 44
Page: 367-372
PDF size: 174.15 Kb.


ABSTRACT

Diabetes mellitus is one of the diseases with the highest incidence in the Mexican population and whose incidence is growing. However, as any disease that affects the human being also has components at the level of the psyche; which can be related to the development of psychiatric comorbidities such as depression, anxiety and binge eating disorder. The latest is important because diet is an indispensable factor for glycemic control in patients with diabetes mellitus. Material and methods: Observational, extensive and transversal study. Patients with type 2 diabetes mellitus were studied under medical treatment, to whom The Binge Eating Scale instrument (16-SF), Hamilton depression questionnaire and Beck’s anxiety inventory were applied. Results: 98 cases of patients with diabetes mellitus with an average age of 55.92 ± 11.28 years were included. A prevalence of depression of 71.4%, anxiety 42.9% and binge eating disorder of 28.66% was found. Binge eating disorder was significantly related to the presence of depression and anxiety (p ‹ 0.0001). Conclusion: Diabetes mellitus is also characterized by presenting psychiatric disorders such as depression, anxiety and binge eating disorder; that is perpetuated by the development of depression and anxiety that have been described as possible biological complications of diabetes mellitus.


REFERENCES

  1. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2019. Diabetes Care. 2019; 42 (Suppl 1): S13-S28.

  2. Hernández-Romieu AC, Elnecavé-Olaiz A, Huerta-Uribe N, Reynoso-Noverón N. Análisis de una encuesta poblacional para determinar los factores asociados al control de la diabetes mellitus en México. Salud Publica Mex. 2011; 53 (1): 34-39.

  3. Iglay K, Hannachi H, Joseph Howie P, Xu J, Li X, Engel SS et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016; 32 (7): 1243-1252.

  4. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008; 121 (11 Suppl 2): S8-S15.

  5. Violante ORM. Obesidad y diabetes tipo 2 en el niño. Una nueva epidemia. Rev Endocrinol Nutr. 2001; 9 (2): 103-106.

  6. Cabrera-Pivaral CE, González-Pérez G, Vega-López MG, Arias-Merino ED. Impacto de la educación participativa en el índice de masa corporal y glicemia en individuos obesos con diabetes tipo 2. Cad Saúde Pública. 2004; 20 (1): 275-281.

  7. Hernández-Escalante V, Trava-García M, Bastarrachea-Sosa R, Laviada-Molina H. Trastornos bioquímicos y metabólicos de la bulimia nervosa y la alimentación compulsiva. Salud Mental. 2003; 26 (3): 9-15.

  8. Association AP. Guía de consulta de los criterios diagnósticos del DSM-5® [Spanish Edition of the Desk Reference to the Diagnostic Criteria From DSM-5®] American Psychiatric Pub; 2014.

  9. García Palacios A. El trastorno por atracón en el DSM-5. C Med Psicosom. 2014; 110: 70-74.

  10. Goode RW, Cowell MM, Mazzeo SE, Cooper-Lewter C, Forte A, Olayia OI et al. Binge eating and binge-eating disorder in Black women: a systematic review. Int J Eat Disord. 2020; 53 (4): 491-507.

  11. Dmitrzak-Węglarz M, Tyszkiewicz-Nwafor M, Duda J, Paszyńska E, Matuszak-Wojciechowska L, Hanć T et al. Abnormal body weight and food-related behavior in school-aged children as measured by the Children’s Binge Eating Disorder Scale. Clin Child Psychol Psychiatry. 2020; 25 (2): 304-319.

  12. Gormally J, Black S, Daston S, Rardin D. The assessment of binge eating severity among obese persons. Addict Behav. 1982; 7 (1): 47-55.

  13. Grupski AE, Hood MM, Hall BJ, Azarbad L, Fitzpatrick SL, Corsica JA. Examining the Binge Eating Scale in screening for binge eating disorder in bariatric surgery candidates. Obes Surg. 2013; 23 (1): 1-6.

  14. Ruiz TA, Silva IH, Miranda CE. Diagnóstico clínico y psicométrico de la depresión en pacientes de medicina general. Rev Méd Chile. 2001; 129: 627-633.

  15. Vázquez OG, Castillo ER, García AM, Ponce JLA, Avitia MAA, Aguilar SA. Propiedades psicométricas del inventario de ansiedad de Beck (BAI) en pacientes con cáncer. Psicooncología. 2015; 12 (1): 51-58.

  16. Sanz J, García-Vera MP, Fortún M. El “Inventario de ansiedad de Beck” (BAI): propiedades psicométricas de la versión española en pacientes con trastornos psicológicos. Psicología Conductual. 2012; 20 (3): 563-583.

  17. INEGI. Población. Disponible en: https://www.inegi.org.mx/temas/estructura/2015.

  18. Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N. Diabetes mellitus en México: el estado de la epidemia. Salud Pública Méx. 2013; 55: s129-s136.

  19. Akirov A, Dicker D, Shochat T, Shimon I. Mortality risk in admitted patients with diabetes mellitus according to treatment. J Diabetes Complications. 2016; 30 (6): 1025-1031.

  20. Tandon R, Luxami V, Dosanjh HS, Tandon N, Paul K. Insulin therapy for diabetes epidemic: a patent review. Curr Drug Deliv. 2018; 15 (6): 777-794.

  21. Castillo-Quan JI, Barrera-Buenfil DJ, Pérez-Osorio JM, Álvarez-Cervera FJ. Depresión y diabetes: de la epidemiología a la neurobiología. Rev Neurol. 2010; 51 (6): 347-359.

  22. Castillo-Quan JI. Insulin resistance, hypercortisolism, polycystic ovarian syndrome, and depression-nonrandom associations? Fertily Steril. 2008; 89 (4): 1029-1030.

  23. Pineda N, Bermúdez V, Cano C, Mengual E, Romero J, Medina M et al. Niveles de Depresión y Sintomatología característica en pacientes adultos con diabetes mellitus tipo 2. AVFT. 2004; 23 (1): 74-78.

  24. Rivas-Acuña V, García-Barjau H, Cruz-León A, Morales-Ramón F, Enríquez-Martínez RM, Román-Alvarez J. Prevalencia de ansiedad y depresión en las personas con diabetes mellitus tipo 2. Salud en Tabasco. 2011; 17 (1-2): 30-35.

  25. Mezuk B, Eaton WW, Albrecht S, Golden SH. Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care. 2008; 31 (12): 2383-2390.

  26. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24 (6): 1069-1078.

  27. Gomez R, Vargas CR, Wajner M, Barros HM. Lower in vivo brain extracellular GABA concentration in diabetic rats during forced swimming. Brain Res. 2003; 968 (2): 281-284.

  28. Rowland NE, Bellush LL. Diabetes mellitus: stress, neurochemistry and behavior. Neurosci Biobehav Rev. 1989; 13 (4): 199-206.

  29. Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S et al. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2007; 30 (1): 83-88.

  30. Fujinami A, Ohta K, Obayashi H, Fukui M, Hasegawa G, Nakamura N et al. Serum brain-derived neurotrophic factor in patients with type 2 diabetes mellitus: Relationship to glucose metabolism and biomarkers of insulin resistance. Clin Biochem. 2008; 41 (10-11): 812-817.

  31. Yu H, Chen ZY. The role of BDNF in depression on the basis of its location in the neural circuitry. Acta Pharmacol Sin. 2011; 32 (1): 3-11.

  32. Herbert J. Cortisol and depression: three questions for psychiatry. Psychol Med. 2013; 43 (3): 449-469.

  33. Ortiz M, Ortiz E, Gatica A, Gómez D. Factores psicosociales asociados a la adherencia al tratamiento de la diabetes mellitus tipo 2. Terapia Psicológica. 2011; 29 (1): 5-11.

  34. Matud MP, Guerrero K, Matías RG. Relevancia de las variables sociodemográficas en las diferencias de género en depresión. Int J Clin Health Psychol. 2006; 6 (1): 7-21.

  35. Raffield LM, Brenes GA, Cox AJ, Freedman BI, Hugenschmidt CE, Hsu FC et al. Associations between anxiety and depression symptoms and cognitive testing and neuroimaging in type 2 diabetes. J Diabetes Complications. 2016; 30 (1): 143-149.

  36. Bystritsky A, Danial J, Kronemyer D. Interactions between diabetes and anxiety and depression: implications for treatment. Endocrinol Metab Clin North Am. 2014; 43 (1): 269-283.

  37. Smith KJ, Beland M, Clyde M, Gariepy G, Page V, Badawi G et al. Association of diabetes with anxiety: a systematic review and meta-analysis. J Psychosom Res. 2013; 74 (2): 89-99.

  38. Hasan SS, Clavarino AM, Mamun AA, Kairuz T. Anxiety symptoms and the risk of diabetes mellitus in Australian women: evidence from 21-year follow-up. Public Health. 2016; 130: 21-28.

  39. López-Aguilar X, Mancilla-Díaz JM, Vázquez-Arévalo R, Téllez-Girón MTO, Franco-Paredes K, Alvarez-Rayón GL. Factores predictores del atracón alimentario en una muestra comunitaria de mujeres mexicanas. JBHSI. 2010; 2 (1): 25-38.

  40. Cuadro E, Baile JI. El trastorno por atracón: análisis y tratamientos Rev Mex Trastor Aliment. 2015; 6: 97-107.

  41. Abbott S, Dindol N, Tahrani AA, Piya MK. Binge eating disorder and night eating syndrome in adults with type 2 diabetes: a systematic review. J Eat Disord. 2018; 6: 36.

  42. Morales Pernalete AR, Gordillo Gutierrez CA, Pérez Alvarado CJ, Marcano Flores DA, Pérez Pérez FA, Flores Navas HL et al. Factores de riesgo para los trastornos por atracón (TA) y su asociación con la obesidad en adolescentes. Gac Med Mex. 2014; 150 (Suppl: 1): 125-131.

  43. Guisado JA, Vaz FJ. Aspectos clínicos del trastorno por atracón “binge eating disorder”. Rev Asoc Esp Neuropsiq. 2001; (77): 27-32.

  44. Racicka E, Bryńska A. Eating disorders in children and adolescents with type 1 and type 2 diabetes: prevalence, risk factors, warning signs. Psychiatr Pol. 2015; 49 (5): 1017-24.




2020     |     www.medigraphic.com